Amaryl 2 MG Tablet is a long-acting oral anti-diabetic which lowers the blood sugar level. It is used only in patients diagnosed with Type II Diabetes. It may be used along with Insulin or other medicines in order to achieve better control over the blood sugar levels. Amaryl contains Glimepiride. Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. Glimepiride is the first third-generation sulfonylurea, and is very potent.
Glimepiride stimulates the insulin release from functioning pancreatic β-cells and inhibits gluconeogenesis at hepatic cells. It also increases insulin sensitivity at peripheral target sites.
Amaryl is product from Sanofi. Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013.
Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world’s largest producer of the latter through its subsidiary Sanofi Pasteur).